Eberconazole
CAS: 128326-82-9
Ref. 3D-DFA32682
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- 1-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-1H-imidazole
- 1H-Imidazole, 1-(2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-
Eberconazole is an analog of a protein kinase inhibitor that has been shown to have anticancer properties. It is used in the treatment of various types of cancer and tumors in humans. Eberconazole works by inhibiting cyclin-dependent kinases, which are enzymes involved in cell division and growth. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Eberconazole has been found to be effective against Chinese hamster ovary (CHO) cells and has shown promise as a potential anticancer drug. It is excreted primarily through urine after administration.
Propiedades químicas
Consulta técnica sobre: 3D-DFA32682 Eberconazole
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
